Free Shipping on All Orders $75 Or More!

Your Trusted Brand for Over 35 Years

Health Protocols

Myasthenia Gravis

Integrative Interventions

Vitamin D

Vitamin D plays an important regulatory role in the immune system. Our bodies produce vitamin D in the skin through exposure to sunlight, and some foods are fortified with vitamin D (MedlinePlus 2014; Hewison 2012; O'Donnell 2008). However, it is difficult to obtain optimal blood vitamin D levels through these sources alone because people tend to spend less time outdoors than in the past (MedlinePlus 2014). A pilot study in 2012 showed that supplementation with vitamin D has beneficial effects on autoimmune response and may alleviate fatigue associated with myasthenia gravis. The researchers demonstrated that 16 patients with myasthenia gravis had 26% lower baseline serum levels of vitamin D than 50 healthy patients (20 ng/mL vs. 27 ng/mL). Thirteen myasthenia gravis patients treated with vitamin D (800 IU/day) had 22% higher serum vitamin D levels and a 38% improvement in muscle fatigue. Researchers suggest that serum vitamin D levels should be monitored in patients with myasthenia gravis and supplementation should be considered if levels are found to be inadequate (Askmark 2012).


Extracts of astragalus have been used for centuries as an herbal remedy for cardiovascular disorders, hepatitis, kidney disease, and skin problems. Astragalus is composed of saponins, polysaccharides, and flavonoids. The most prevalent saponin with medicinal activity identified in astragalus is astragaloside IV. Numerous experimental studies have demonstrated that astragaloside IV improves cardiac function, promotes blood vessel growth, inhibits fibrosis in different organs, and regulates immune function (Ren 2013). In a 2009 study comparing the effects of astragalus and the steroid prednisone on immune response in 60 myasthenia gravis patients, astragalus was as effective as prednisone for reducing symptoms of myasthenia gravis. Also, astragalus was more effective than prednisone for reducing ratios of CD4+/CD8+ T cells (Niu 2009).


Creatine is an organic acid produced by the body that is also present in food — primarily meat. Creatine supplementation helps increase lean body mass, muscle strength, and energy; it also improves active performance in healthy individuals and patients with neuromuscular diseases such as muscular dystrophy (Kley 2013; Stout 2001). An analysis of 6 randomized, controlled trials in muscle diseases reported that patients who supplemented with creatine had a significant improvement in muscle strength versus placebo-treated patients, with a mean difference of 8.5%. Patients from 4 trials receiving creatine also reported an overall improvement in well-being (Kley 2013). Creatine supplementation has also been reported to help patients with myasthenia gravis. A 26-year old man with myasthenia gravis who self-administered 5 g of creatine daily for 15 weeks combined with resistance exercise training, along with prednisone and azathioprine, had significant improvements in muscle strength, body weight, and fat free mass (Stout 2001).

Other Natural Agents with Potential Benefit in Myasthenia Gravis

Several natural interventions have been studied in the context of diseases that may share some underlying pathological features with myasthenia gravis such as inflammation, autoimmunity, and perturbed acetylcholine signaling. However, these agents have not been investigated in clinical trials involving myasthenia gravis patients as of the time of this writing. More research is required to elucidate the potential benefits of these agents for those with myasthenia gravis.


Proposed Mechanism


Omega-3 Fatty Acids

Anti-inflammatory (eg, suppresses TNF-α and IL-1β production)

(Maroon 2010; Weiss 2002; Galarraga 2008; Park 2013; Wright 2008)

Green Tea Extract

Anti-inflammatory (eg, suppresses TNF-α, various interleukins, and IFN-gamma); modulation of oxidative stress (eg, induction of antioxidant genes)

(Wang 2012; Kim 2008; Peairs 2010; Wu 2012; Bettuzzi 2006; Yiannakopoulou 2013)

Cat’s Claw (Uncaria tomentosa)

Anti-inflammatory, immune modulation (eg, suppresses NF-κB and TNF-α)

(Maroon 2010; Sandoval 2000)

Vitamin D

Immune modulation (eg, helps regulate innate and adaptive immunity)

(Maggini 2007; O'Brien 2012)

Peony (Paeonia lactiflora)

Anti-inflammatory (eg, inhibits production of prostaglandin E2, leukotriene B4, and nitric oxide); immune modulation (eg, modulates lymphocyte proliferation)

(He 2011; Zhang 2011; Chen 2013; Lin 2012; Zhou 2012; Wang, Xing 2007; Du 2005; Wang 2014; Wang, Wang 2007)

Huperzine A

Acetylcholinesterase inhibitor

(Orhan 2013; Zhang 2002)


Anti-inflammatory (eg, suppresses TNF-α, IL-1, IL-2, IL-6, IL-8, IL-12, and chemokines); immune modulation (eg, modulates activation of T cells, B cells, macrophages, neutrophils, natural killer cells, and dendritic cells); acetylcholinesterase inhibitor

(Orhan 2013; Jurenka 2009; Jagetia 2007)


Anti-inflammatory (eg, modulates gene expression of inflammatory factors including IL-1R, CcI8, IKK, and STAT3)

(Orhan 2013; Mahmoud 2013; Heinz 2010; Bae 2009; Boots 2011; Kleemann 2011)

Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the treatments discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. The publisher has not performed independent verification of the data contained herein, and expressly disclaim responsibility for any error in literature.